Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech IncfiledCriticalGenentech Inc
Priority claimed from PCT/US2017/052891external-prioritypatent/WO2018057849A1/en
Publication of CR20190176ApublicationCriticalpatent/CR20190176A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
Uses of IL-13 antagonists for treating atopic dermatitis are provided. Also provided are methods of treating atopic dermatitis and methods of reducing the severity of atopic dermatitis by administering IL-13 antagonists.Se proveen usos de antagonistas de IL-13 para el tratamiento de dermatitis atópica. Se proveen también métodos para el tratamiento de dermatitis atópica y métodos para la reducción de la gravedad de la dermatitis atópica mediante la administración de antagonistas de IL-13.
CR20190176A2016-09-232017-09-22Uses of il-13 antagonists for treating atopic dermatitis
CR20190176A
(en)